Target Price | CNY69.87 |
Price | CNY63.17 |
Potential |
10.61%
register free of charge
|
Number of Estimates | 15 |
15 Analysts have issued a price target Fuyao Glass Industry Group 2026 .
The average Fuyao Glass Industry Group target price is CNY69.87.
This is
10.61%
register free of charge
CNY86.73
37.30%
register free of charge
CNY56.56
10.46%
register free of charge
|
|
A rating was issued by 24 analysts: 22 Analysts recommend Fuyao Glass Industry Group to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Fuyao Glass Industry Group stock has an average upside potential 2026 of
10.61%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CNY | 39.25 | 46.54 |
18.37% | 18.57% | |
EBITDA Margin | 22.56% | 28.20% |
12.66% | 25.00% | |
Net Margin | 19.10% | 19.48% |
12.53% | 1.98% |
20 Analysts have issued a sales forecast Fuyao Glass Industry Group 2025 . The average Fuyao Glass Industry Group sales estimate is
This results in the following potential growth metrics:
21 Fuyao Glass Industry Group Analysts have issued a net profit forecast 2025. The average Fuyao Glass Industry Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CNY | 2.87 | 3.47 |
32.87% | 20.91% | |
P/E | 18.19 | |
EV/Sales | 3.59 |
21 Analysts have issued a Fuyao Glass Industry Group forecast for earnings per share. The average Fuyao Glass Industry Group EPS is
This results in the following potential growth metrics and future valuations:
Fuyao Glass Industry Group...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.